Characterizing Multimodal Mutational Processes in Cancer Using MOTET
Jiaqi SuniD, Kelly L. GeyeriD, Natasha Q. GurevichiD, Tao GuoiD, Masanao YajimaiD, Jonathan H. HugginsiD, Joshua D. CampbelliD
Abstract
Mutational signatures are characteristic patterns of somatic alterations in cancer genomes. A single aberrant mechanism can simultaneously generate coordinated patterns of alterations across multiple mutation modalities, including single-base substitutions (SBSs), doublet-base substitutions (DBSs), and small insertions and deletions (IDs). However, these signatures are typically inferred separately and linked post hoc, obscuring their shared underlying mechanisms. To resolve this, we formally define a Mutational Process (MP) as a unified latent activity that induces coupled mutational signatures across these modalities. We developed MOTET, a Bayesian framework that jointly infers multimodal MPs. Applied to 2,583 whole genomes from the PCAWG cohort, MOTET recovers known MPs more accurately than standard post hoc correlation methods. MOTET also identifies a process linking an SBS37-related signature with a TG>CA-dominated DBS component and resolves canonical SBS12-like activity into two separate MPs with distinct tissue distributions. These results establish a paradigm for formally defining catalogs of MPs and demonstrate that integrating across modalities enhances the ability to discover new mutational patterns.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Correlation-aware discovery of co-occurring mutational signatures in cancer
Hu Jin, Benedikt Geiger, … Peter J. Park·bioRxiv·Sep 21, 2026
- De Novo Mutational Signature Discovery in Tumor Genomes using SparseSignatures
Avantika Lal, Keli Liu, … Daniele Ramazzotti·PLoS Computational BiologyPeer-reviewed·Jun 28, 2021
- Hidden Markov Models Lead to Higher Resolution Maps of Mutation Signature Activity in Cancer
Xiaoqing Huang, Itay Sason, … Roded Sharan·Genome MedicinePeer-reviewed·Jul 26, 2019
- Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer
Yoo-Ah Kim, Damian Wójtowicz, … Teresa M. Przytycka·Genome MedicinePeer-reviewed·May 29, 2020
- Damage and Misrepair Signatures: Compact Representations of Pan-cancer Mutational Processes
Caitlin F. Harrigan, Kieran R. Campbell, … Tyler Funnell·bioRxiv·May 29, 2025
- Learning mutational signatures and their multidimensional genomic properties with TensorSignatures
H. Vohringer, A. van Hoeck, … M. Gerstung·bioRxiv·Jun 19, 2020